Parabilis Medicines Inc, formerly known as Fog Pharmaceuticals Inc, is a United States-based company. The Company operates as a clinical-stage biopharmaceutical company. It is focused on discovering and developing transformative medicines that target disease-driving proteins historically considered “undruggable.” It leverages its Helicon platform, which consists of engineered, stabilized, cell‑penetrant helical peptides designed to bind and modulate intracellular protein targets with high specificity and affinity. Its pipeline primarily focuses on oncology, with programs such as zolucatetide being evaluated in clinical trials for solid tumors. more
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| PBLS | |
|---|---|
| ROA (LTM) | 0.00% |
| ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| PBLS | |
|---|---|
| Trailing PE | NM |
| Forward PE | NM |
| P/S (TTM) | 0.00 |
| P/B | 0.00 |
| EV/R | 0.00 |
| EV/Ebitda | NM |
PARABILIS MEDICINES INC (PBLS) share price today is $31.054
Yes, Indians can buy shares of PARABILIS MEDICINES INC (PBLS) on Vested. To buy
Yes, you can purchase fractional shares of PARABILIS MEDICINES INC (PBLS) via the Vested app. You can start investing in PARABILIS MEDICINES INC (PBLS) with a minimum investment of $1.
You can invest in shares of PARABILIS MEDICINES INC (PBLS) via Vested in three simple steps:
The 52-week high price of PARABILIS MEDICINES INC (PBLS) is $. The 52-week low price of PARABILIS MEDICINES INC (PBLS) is $.
The price-to-earnings (P/E) ratio of PARABILIS MEDICINES INC (PBLS) is
The price-to-book (P/B) ratio of PARABILIS MEDICINES INC (PBLS) is 0.00
The dividend yield of PARABILIS MEDICINES INC (PBLS) is 0.00%
The market capitalization of PARABILIS MEDICINES INC (PBLS) is
The stock symbol (or ticker) of PARABILIS MEDICINES INC is PBLS
Consider the share price of PARABILIS MEDICINES INC as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether PARABILIS MEDICINES INC has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in PARABILIS MEDICINES INC shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the PARABILIS MEDICINES INC stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of PARABILIS MEDICINES INC and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that PARABILIS MEDICINES INC stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied
